{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:34:17Z","timestamp":1765546457818,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Tehran university of medical sciences","award":["94-02-27-28841"],"award-info":[{"award-number":["94-02-27-28841"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.molimm.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T18:31:29Z","timestamp":1556735489000},"page":"152-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A non-pathogenic Leishmania tarentolae vector based- HCV polytope DNA vaccine elicits potent and long lasting Th1 and CTL responses in BALB\/c mice model"],"prefix":"10.1016","volume":"111","author":[{"given":"Nastaran","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Roohvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zamaneh","family":"Hajikhezri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayoun","family":"Samimi-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2019.04.009_bib0005","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2217\/imt-2017-0076","article-title":"Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB\/c mice","volume":"9","author":"Abdossamadi","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.molimm.2019.04.009_bib0010","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3390\/ijms18081626","article-title":"Unsolved puzzles surrounding HCV immunity: heterologous immunity adds another dimension","volume":"18","author":"Agrawal","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.molimm.2019.04.009_bib0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, progress, and challenges to hepatitis C vaccine development","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molimm.2019.04.009_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virusres.2018.02.016","article-title":"Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies","volume":"248","author":"Bartenschlager","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.molimm.2019.04.009_bib0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12033-009-9213-5","article-title":"Recombinant protein expression in Leishmania tarentolae","volume":"43","author":"Basile","year":"2009","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tips.2017.06.002","article-title":"An overview of novel adjuvants designed for improving vaccine efficacy","volume":"38","author":"Bonam","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molimm.2019.04.009_bib0035","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1128\/IAI.73.10.6372-6382.2005","article-title":"Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis","volume":"73","author":"Breton","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.04.009_bib0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1099\/vir.0.81995-0","article-title":"A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection","volume":"88","author":"Breton","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0045","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1016\/j.vaccine.2007.08.020","article-title":"An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses","volume":"25","author":"Fournillier","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.04.009_bib0050","first-page":"20","article-title":"Generic treatments for HIV, HBV, HCV, TB could be mass produced for< $90 per patient","author":"Hill","year":"2017","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.molimm.2019.04.009_bib0055","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/imr.12642","article-title":"Memory vs memory-like: the different facets of CD 8+ T-cell memory in HCV infection","volume":"283","author":"Hofmann","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2019.04.009_bib0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/10717544.2013.801534","article-title":"A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers","volume":"20","author":"Hosseinzadeh","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.molimm.2019.04.009_bib0065","doi-asserted-by":"crossref","first-page":"16107","DOI":"10.1038\/s41598-018-34254-5","article-title":"Exploring NS3\/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches","volume":"8","author":"Ikram","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2019.04.009_bib0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.vaccine.2015.11.062","article-title":"Prime-boost vaccine strategy against viral infections: mechanisms and benefits","volume":"34","author":"Kardani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.04.009_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2015.08.001","article-title":"Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB\/c mice model","volume":"67","author":"Katebi","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0080","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1099\/vir.0.011684-0","article-title":"Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice","volume":"90","author":"Kovacs-Nolan","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/pim.12315","article-title":"DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control","volume":"38","author":"Kumar","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.21992","article-title":"Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB\/c mice","volume":"47","author":"Liao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.molimm.2019.04.009_bib0095","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/092986609788681788","article-title":"Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB\/c mice","volume":"16","author":"Memarnejadian","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.molimm.2019.04.009_bib0100","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1001877","article-title":"Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain","author":"Mikkelsen","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vaccine.2009.09.114","article-title":"Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis","volume":"28","author":"Mizbani","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.04.009_bib0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/13880209.2015.1048371","article-title":"Co-expression of hepatitis C virus polytope\u2013HBsAg and p19-silencing suppressor protein in tobacco leaves","volume":"54","author":"Mohammadzadeh","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0115","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12461","article-title":"Leishmania tarentolae expressing CXCL\u201010 as an efficient immunotherapy approach against Leishmania major\u2010infected BALB\/c mice","volume":"39","author":"Montakhab-Yeganeh","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0120","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.06420-11","article-title":"Production of a particulate hepatitis C vaccine candidate by engineered Lactococcus lactis","author":"Parlane","year":"2011","journal-title":"Appl. Environ. Microbial. AEM."},{"key":"10.1016\/j.molimm.2019.04.009_bib0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00705-014-2243-8","article-title":"Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96","volume":"160","author":"Pishraft-Sabet","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.21775\/cimb.022.129","article-title":"DNA vaccine delivery and improved immunogenicity","volume":"22","author":"Porter","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0135","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/gt.2016.55","article-title":"T-and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates","volume":"23","author":"Rollier","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.molimm.2019.04.009_bib0140","first-page":"14","article-title":"Immunogenicity of multi-epitope DNA and peptide vaccine candidates based on core, E2, NS3 and NS5B HCV epitopes in BALB\/c mice","author":"Sabet","year":"2014","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.molimm.2019.04.009_bib0145","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2217\/imt.12.110","article-title":"Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model","volume":"4","author":"Salehi","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.molimm.2019.04.009_bib0150","doi-asserted-by":"crossref","first-page":"e2174","DOI":"10.1371\/journal.pntd.0002174","article-title":"Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis","volume":"7","author":"Saljoughian","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"year":"2006","series-title":"The Condensed Protocols from Molecular Cloning: a Laboratory Manual","author":"Sambrook","key":"10.1016\/j.molimm.2019.04.009_bib0155"},{"key":"10.1016\/j.molimm.2019.04.009_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132794","article-title":"Evaluation of live recombinant nonpathogenic Leishmania tarentolae expressing cysteine proteinase and A2 genes as a candidate vaccine against experimental canine visceral leishmaniasis","volume":"10","author":"Shahbazi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.04.009_bib0165","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/vim.2006.19.702","article-title":"Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes","volume":"19","author":"Shi","year":"2006","journal-title":"Viral Immunol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0170","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12072-017-9805-2","article-title":"Current progress in host innate and adaptive immunity against hepatitis C virus infection","volume":"11","author":"Shi","year":"2017","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.molimm.2019.04.009_bib0175","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1007\/s00253-016-7712-4","article-title":"Leishmania-based expression systems","volume":"100","author":"Taheri","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181578","article-title":"Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens","volume":"12","author":"Tan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.04.009_bib0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4254\/wjh.v7.i1.53","article-title":"Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees","volume":"7","author":"Verstrepen","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coi.2015.06.010","article-title":"Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?","volume":"35","author":"Walker","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molimm.2019.04.009_bib0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gutjnl-2016-312208","article-title":"Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model","volume":"67","author":"Yokokawa","year":"2018","journal-title":"Gut"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018309994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018309994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:32:48Z","timestamp":1758979968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018309994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":39,"alternative-id":["S0161589018309994"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.04.009","relation":{},"ISSN":["0161-5890"],"issn-type":[{"type":"print","value":"0161-5890"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A non-pathogenic Leishmania tarentolae vector based- HCV polytope DNA vaccine elicits potent and long lasting Th1 and CTL responses in BALB\/c mice model","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}